MN gene and protein

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 7910691
SERIAL NO

11929351

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

Identified herein is the location of the MN protein binding site, and MN proteins/polypeptides that compete for attachment to vertebrate cells with immobilized MN protein. Such MN proteins/polypeptides prevent cell-cell adhesion and the formation of intercellular contacts. The MN protein binding site is a therapeutic target that can be blocked by organic or inorganic molecules, preferably organic molecules, more preferably proteins/polypeptides that specifically bind to that site. Therapeutic methods for inhibiting the growth of preneoplastic/neoplastic vertebrate cells that abnormally express MN protein are disclosed. Vectors are provided that encode the variable domains of MN-specific antibodies and a flexible linker polypeptide separating those domains. Further vectors are disclosed that encode a cytotoxic protein/polypeptide operatively linked to the MN gene promoter, and which vectors preferably further encode a cytokine. The MN gene promoter is characterized, and the binding site for a repressor of MN transcription is disclosed.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
BIOMEDICAL RESEARCH CENTRE OF THE SLOVAK ACADEMY OF SCIENCESDÚBRAVSKA CESTA 9 BRATISLAVA

International Classification(s)

  • [Classification Symbol]
  • [Patents Count]

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Pastorek, Jaromir Bratislava, SK 54 371
Pastorekova, Silvia Bratislava, SK 52 371
Zavada, Jan Prague, CZ 40 312

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation